CytexOrtho

Read more here: https://www.pharmexec.com/view/osteoarthritis-is-a-cure-on-the-launch-pad-

Are you at ACA? Stop by and see us, tabletop 21. We would love to connect, and share about our breakthrough technology. We are positioned to disrupt the untapped market of hip cartilage regeneration.

Check it out! CytexOrtho CEO and Co-founder, Brad Estes, is heading to Washington, D.C.!

Marking National Arthritis Awareness Month in May, we and the Arthritis Foundation are hosting the first annual OA Innovation “Shark Tank” meeting on Capitol Hill on May 11th to spotlight the promise of new treatments to cure osteoarthritis.

Speakers include:

➡ Congressman Gerry Connolly
➡ Rep. Debbie Dingell
➡ Dr. Elizabeth “Blair” Solow, M.D., Associate Professor of Rheumatology, UT Southwestern Medical Center
➡ Dr. Ivan Martin, Chair of the Department of Biomedicine, Universität Basel
➡ Dr. Jennifer Elisseeff, Director of the Translational Tissue Engineering Center, Johns Hopkins University
➡ Dr. Brad Estes, CEO and founder, CytexOrtho
➡ Dr. Yusuf Yazici, Chief Medical Officer, Biosplice Therapeutics
➡ Steve O’Keeffe, founder, Angry@Arthritis
➡ Anna Hyde, Vice President of Advocacy and Access, Arthritis Foundation

Register: https://www.angryarthritis.org/oa-innovation-shark-tank/

Follow us at CytexOrtho as we break into the untapped market of hip cartilage restoration! Learn more at www.cytexortho.com.

CytexOrtho was invited to pitch last week at the MedTech Innovator East Coast Event! To learn more about CytexOrtho, visit our website at www.cytexortho.com.

Learn more about our breakthrough device designation from the FDA! https://cytexortho.com/2023/01/breakthrough-device-designation-from-the-fda/

Take a look behind the scenes! Learn more about us at www.cytexortho.com.

Take a look behind the scenes! To learn more, visit us at www.cytexortho.com.

FINAL HOURS to become a shareholder in CytexOrtho!

Join industry leading orthopedic surgeons and invest today! www.startengine.com/cytex